Beyond Medical Technologies Inc.
DOCT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -13.26% | -19.95% | -18.54% | -38.32% | -29.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.26% | -19.95% | -18.54% | -38.32% | 311.20% |
| Operating Income | 13.26% | 19.95% | 18.54% | 38.32% | 8.65% |
| Income Before Tax | 36.95% | 41.33% | 26.20% | 36.59% | 44.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.95% | 41.33% | 26.20% | 36.59% | 44.91% |
| Earnings from Discontinued Operations | 86.94% | 94.40% | 92.56% | 93.49% | 52.37% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.27% | 62.04% | 55.17% | 61.05% | 69.87% |
| EBIT | 13.26% | 19.95% | 18.54% | 38.32% | 8.65% |
| EBITDA | -- | -- | -- | -- | 74.11% |
| EPS Basic | 49.38% | 62.22% | 55.29% | 61.12% | 70.42% |
| Normalized Basic EPS | 14.83% | 21.12% | 17.36% | 36.67% | 46.17% |
| EPS Diluted | 49.38% | 62.22% | 55.29% | 61.12% | 70.42% |
| Normalized Diluted EPS | 14.83% | 21.12% | 17.36% | 36.67% | 46.17% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 1.20% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 1.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
